News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WOODHOUSE DAVID J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| WOODHOUSE DAVID J (Director) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 20,000 options to buy
@ $0.56, valued at
$11.2k
|
|
| 03/06/2023 |
4
| WOODHOUSE DAVID J (CEO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 127,200 shares
@ $0
Granted 381,600 options to buy
@ $4.36, valued at
$1.7M
Granted 500,000 options to buy
@ $4.36, valued at
$2.2M
|
|
| 06/09/2022 |
4
| WOODHOUSE DAVID J (Director) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 20,000 options to buy
@ $2.79, valued at
$55.8k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| WOODHOUSE DAVID J (CEO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Sold 15,000 shares
@ $20.02, valued at
$300.3k
Exercised 15,000 options to buy
@ $7.54, valued at
$113.1k
|
|
| 08/16/2021 |
3
| WOODHOUSE DAVID J (Director) has filed a Form 3 on Surrozen, Inc./DE |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
3
| WOODHOUSE DAVID J (CEO and acting CFO) has filed a Form 3 on NGM BIOPHARMACEUTICALS INC |
|
|